Drug resistance

  • Authors:
    • B Hill
  • View Affiliations

  • Published online on: August 1, 1996     https://doi.org/10.3892/ijo.9.2.197
  • Pages: 197-203
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

An overview of the current mechanisms identified as associated with the expression of multidrug resistance is provided. The clinical relevance of multidrug resistance associated with the overexpression of the three major drug resistance-associated proteins namely, P-glycoprotein, MRP and/or LRP, is discussed. Alternate forms of multidrug resistance involving the reduced or altered expression of either or both of the topoisomerases is next considered, followed by a short section relating to resistance to the platinum complexes and the contribution of altered DNA repair. For those involved in new drug discovery programmes for cancer chemotherapy, the identification and study of these new major intracellular targets makes this an exciting era.

Related Articles

Journal Cover

August 1996
Volume 9 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hill B: Drug resistance. Int J Oncol 9: 197-203, 1996
APA
Hill, B. (1996). Drug resistance. International Journal of Oncology, 9, 197-203. https://doi.org/10.3892/ijo.9.2.197
MLA
Hill, B."Drug resistance". International Journal of Oncology 9.2 (1996): 197-203.
Chicago
Hill, B."Drug resistance". International Journal of Oncology 9, no. 2 (1996): 197-203. https://doi.org/10.3892/ijo.9.2.197